JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dirig, D. M.
Right arrow Articles by Yaksh, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dirig, D. M.
Right arrow Articles by Yaksh, T. L.

Vol. 285, Issue 3, 1031-1038, June 1998

Effect of COX-1 and COX-2 Inhibition on Induction and Maintenance of Carrageenan-Evoked Thermal Hyperalgesia in Rats1

David M. Dirig, Peter C. Isakson and Tony L. Yaksh

Departments of Anesthesiology (T.L.Y.) and Pharmacology (D.M.D., T.L.Y.), University of California, San Diego, California

Intrathecal administration of nonsteroidal anti-inflammatory drugs in the rat blocks the thermal hyperalgesia induced by tissue injury, which suggests a role for spinal cyclooxygenase (COX) products in this facilitated state. Two isozymes of the COX enzyme have been reported, COX-1 and COX-2, but the agents thus far examined are not isozyme selective. We examined the effects of intrathecally (i.t.) or systemically (i.p.) administered S(+)-ibuprofen (a nonselective COX inhibitor) or 1-[(4-methysulfonyl)phenyl]-3-tri-fluoromethyl-5-(4-fluorophenyl) pyrazole (SC58125; a COX-2 selective inhibitor) on carrageenan-induced thermal hyperalgesia (reduced hindpaw-withdrawal latency). The following observations were made: 1) Thermal hyperalgesia otherwise observed during the first 170 min was blocked in a dose-dependent manner by S(+)-ibuprofen or SC58125 administered i.t. or i.p. before carrageenan treatment. 2) Intraperitoneal, but not i.t., administration of either inhibitor after the establishment of hyperalgesia (170 min after carrageenan injection) reversed thermal hyperalgesia in a dose-dependent manner. Thus, the initial component of thermal hyperalgesia after tissue injury was blocked by systemic or spinal administration of both COX inhibitors, whereas established hyperalgesia was reversed only by systemic inhibitors. This study demonstrates that at least spinal COX-2, if not both COX-1 and COX-2, are necessary for the initiation of thermal hyperalgesia, whereas nonspinal sources of prostanoids (synthesized by COX-2 and perhaps also COX-1) are important for the maintenance of thermal hyperalgesia associated with tissue injury and inflammation.


0022-3565/98/2853-1031$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Anesth. Analg.Home page
C.-M. Shih, S.-N. Cheng, C.-S. Wong, Y.-L. Kuo, and T.-C. Chou
Antiinflammatory and Antihyperalgesic Activity of C-Phycocyanin
Anesth. Analg., April 1, 2009; 108(4): 1303 - 1310.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. A. Brooks, N. Nametz, R. Charles, and T. P. Davis
Diclofenac Attenuates the Regional Effect of {lambda}-Carrageenan on Blood-Brain Barrier Function and Cytoarchitecture
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 665 - 673.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. L. Chillingworth, S. G. Morham, and L. F. Donaldson
Sex differences in inflammation and inflammatory pain in cyclooxygenase-deficient mice
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R327 - R334.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
D. R. H. Huntjens, M. Danhof, and O. E. Della Pasqua
Pharmacokinetic pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors
Rheumatology, July 1, 2005; 44(7): 846 - 859.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. T. Priest, B. A. Murphy, J. A. Lindia, C. Diaz, C. Abbadie, A. M. Ritter, P. Liberator, L. M. Iyer, S. F. Kash, M. G. Kohler, et al.
Contribution of the tetrodotoxin-resistant voltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behavior
PNAS, June 28, 2005; 102(26): 9382 - 9387.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
X. Zhu, D. R. Conklin, and J. C. Eisenach
Preoperative Inhibition of Cyclooxygenase-1 in the Spinal Cord Reduces Postoperative Pain
Anesth. Analg., May 1, 2005; 100(5): 1390 - 1393.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
L. Shi, P. Lebrun, F. Camu, and M. Zizi
Intrathecal Catheterization and Solvents Interfere with Cortical Somatosensory Evoked Potentials Used in Assessing Nociception in Awake Rats
Anesth. Analg., July 1, 2004; 99(1): 159 - 165.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Guay, K. Bateman, R. Gordon, J. Mancini, and D. Riendeau
Carrageenan-induced Paw Edema in Rat Elicits a Predominant Prostaglandin E2 (PGE2) Response in the Central Nervous System Associated with the Induction of Microsomal PGE2 Synthase-1
J. Biol. Chem., June 4, 2004; 279(23): 24866 - 24872.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Koetzner, X.-Y. Hua, J. Lai, F. Porreca, and T. Yaksh
Nonopioid Actions of Intrathecal Dynorphin Evoke Spinal Excitatory Amino Acid and Prostaglandin E2 Release Mediated by Cyclooxygenase-1 and -2
J. Neurosci., February 11, 2004; 24(6): 1451 - 1458.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T.-C. Chou, L.-P. Chang, C.-Y. Li, C.-S. Wong, and S.-P. Yang
The Antiinflammatory and Analgesic Effects of Baicalin in Carrageenan-Evoked Thermal Hyperalgesia
Anesth. Analg., December 1, 2003; 97(6): 1724 - 1729.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
N. M. Gajraj
Cyclooxygenase-2 Inhibitors
Anesth. Analg., June 1, 2003; 96(6): 1720 - 1738.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Ciceri, Y. Zhang, A. F. Shaffer, K. M. Leahy, M. B. Woerner, W. G. Smith, K. Seibert, and P. C. Isakson
Pharmacology of Celecoxib in Rat Brain after Kainate Administration
J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 846 - 852.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Vasquez, K.-J. Bar, A. Ebersberger, B. Klein, H. Vanegas, and H.-G. Schaible
Spinal Prostaglandins Are Involved in the Development But Not the Maintenance of Inflammation-Induced Spinal Hyperexcitability
J. Neurosci., November 15, 2001; 21(22): 9001 - 9008.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. L. Yaksh, D. M. Dirig, C. M. Conway, C. Svensson, Z. D. Luo, and P. C. Isakson
The Acute Antihyperalgesic Action of Nonsteroidal, Anti-Inflammatory Drugs and Release of Spinal Prostaglandin E2 Is Mediated by the Inhibition of Constitutive Spinal Cyclooxygenase-2 (COX-2) but not COX-1
J. Neurosci., August 15, 2001; 21(16): 5847 - 5853.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
K. Pacak and M. Palkovits
Stressor Specificity of Central Neuroendocrine Responses: Implications for Stress-Related Disorders
Endocr. Rev., August 1, 2001; 22(4): 502 - 548.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. S. Gold
Tetrodotoxin-resistant Na+ currents and inflammatory hyperalgesia
PNAS, July 6, 1999; 96(14): 7645 - 7649.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Lu and K. N. Westlund
Gabapentin Attenuates Nociceptive Behaviors in an Acute Arthritis Model in Rats
J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 214 - 219.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.